导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -15.39% | 919/1050 |
| 近一周 | -4.06% | 979/1104 |
| 近一月 | -4.06% | 501/1102 |
| 近一季 | -6.46% | 489/1092 |
| 近半年 | -12.28% | 823/1070 |
| 近一年 | -20.17% | 903/1018 |
| 近两年 | 26.64% | 710/926 |
| 近三年 | 22.23% | 470/834 |
| 成立以来 | 175.89% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-6.54% 886/1070 |
-11.62% 950/1101 |
- - |
- - |
| 2025 | 25.39% 575/1065 |
5.59% 368/1014 |
6.03% 237/1038 |
21.82% 546/1050 |
-8.06% 833/1065 |
| 2024 | 20.75% 83/1011 |
-0.77% 354/960 |
11.54% 8/983 |
10.60% 578/991 |
-1.36% 405/1011 |
| 2023 | -4.39% 189/952 |
5.66% 278/880 |
-4.51% 494/895 |
-2.57% 184/915 |
-2.74% 299/952 |
| 2022 | -14.13% 155/867 |
-16.63% 342/773 |
8.72% 316/806 |
-10.73% 289/845 |
6.12% 161/867 |
| 2021 | -6.54% 440/740 |
-1.27% 198/580 |
3.23% 497/659 |
-8.29% 458/704 |
- 438/740 |
| 2020 | 45.28% 267/554 |
-13.94% 404/419 |
22.58% 238/466 |
10.70% 235/517 |
24.41% 76/554 |
| 2019 | 39.62% 224/410 |
23.77% 793/1146 |
-3.97% 646/1228 |
4.93% 199/390 |
11.95% 111/410 |
| 2018 | -30.48% 223/349 |
- - |
-6.62% 243/990 |
-7.77% 641/1000 |
-14.95% 874/1080 |
| 2017 | 51.43% 3/285 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 嘉实沪港深精选股票 VS. 东吴新产业精选股票A(580008) |